Advertisement
Screener

Satsuma Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Four

Satsuma Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Four

Satsuma Pharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Four of $833.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2019-11-12

  • 2019-09-30: Long-Term Debt, Maturity, Year Four $833.00K.
Period endLong-Term Debt, Maturity, Year Four
2019-09-30$833.00K
10-Q · filed 2019-11-12